BioMarin Pharmaceutical, Inc. (BMRN)
56.32
+1.73
(+3.17%)
USD |
NASDAQ |
Jan 20, 16:00
56.30
-0.02
(-0.04%)
After-Hours: 17:42
BioMarin Pharmaceutical Market Cap: 10.82B for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Amicus Therapeutics, Inc. | 4.417B |
| Gilead Sciences, Inc. | 154.23B |
| Merck & Co., Inc. | 271.78B |
| AbbVie, Inc. | 378.22B |
| Biogen, Inc. | 24.24B |
Market Cap Related Metrics
| PE Ratio | 21.10 |
| PS Ratio | 3.570 |
| PEG Ratio | 0.3476 |
| Price to Book Value | 1.786 |
| Price to Free Cash Flow | 13.34 |
| Price | 56.32 |
| Earnings Yield | 4.74% |
| PEGY Ratio | 0.3476 |
| Operating PE Ratio | 12.87 |
| Normalized PE Ratio | 15.78 |